Blog

Revolutionizing healthcare through innovative drug delivery systems (DDS) is a pressing need in today's medical landscape. Among the companies leading this on-going need is Murli Krishna Pharma Pvt. Ltd, a prominent player in the pharmaceutical sector that specializes in transdermal delivery systems. This method of drug administration allows for effective treatment while minimizing the invasiveness typically associated with traditional methods.

Dr. Satya Vadlamani, Chairperson and Managing Director of Murli Krishna Pharma Pvt. Ltd. (MKPPL) has been instrumental in transforming the company into a leading pharmaceutical manufacturer and contract research organization. With her unwavering commitment to innovation, quality, and social responsibility, Dr. Vadlamani has steered MKPPL to new heights, making it a beacon of excellence in the industry.

Murli Krishna Pharma has established itself as a prominent player in the pharma industry, particularly noted for its ‘commitment to quality and compliance’. With facilities accredited by the European Union (EU) and the World Health Organization (WHO), the company exemplifies excellence in pharmaceutical manufacturing, ensuring that its products meet stringent international standards.

Murli Krishna Pharma has emerged as a pioneering force in the pharmaceutical industry, particularly known for its innovative Research and Development (R&D) initiatives, with over 200+ happy customers, across 78+ countries. Founded in 2004 by Dr. Satya Vadlamani, CMD and Dr. Vijay K. Shastri, the company has dedicated itself to creating 34+ high-quality pharmaceutical products, that meet international standards like “European Union, WHO, GCC and Jordanian FDA”. This commitment to excellence is reflected in its extensive range of offerings, including “Pre-finished Formulation Intermediates and Finished Dosage forms”.

Murli Krishna Pharma Pvt. Ltd, a leading Indian pharmaceutical company, is playing a pivotal role in supporting the Anemia Mukt Bharat (AMB) mission, a nationwide initiative spearheaded by the Ministry of Health and Family Welfare and UNICEF.

Murli Krishna Pharma Pvt. Ltd, a leading Indian pharmaceutical company, has been at the forefront of combating anemia in the country. With a strong focus on public health and innovation, the company has developed groundbreaking solutions to support the National Health Mission and the government's vision of an Anemia Mukt Bharat, as envisioned by PM Modi and the Ministry of Health and Family Welfare.

Anemia Mukt Bharat (AMB) initiative, launched by the Ministry of Health and Family Welfare in 2018, is a nationwide movement towards a healthier India. This ambitious program aims to eliminate anemia among key population groups, including pregnant women, children, and adolescents, through a comprehensive 6x6x6 strategy.

Anemia, a condition categorized by a lack of healthy red blood cells, can leave you feeling fatigued and weak. However, incorporating certain types of food into your diet can help combat anemia and boost your overall health. By focusing on nutrient-rich foods that are high in iron, vitamin B12, folate, and vitamin C, you can support your body in producing an adequate amount of red blood cells.